TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07049055: A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Sponsor: Engeneic Pty Limited · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 144 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$12,566,400

Rescue Site Savings

+$8,285,970

Unlock Full NCT07049055 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07049055 Rescue Dossier →